SMITH ASSET MANAGEMENT GROUP LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$635,000
-8.4%
28,880
-0.9%
0.03%
-16.2%
Q1 2021$693,000
-56.4%
29,145
-52.1%
0.04%
-59.8%
Q4 2020$1,591,000
+30.4%
60,805
-13.2%
0.09%
+43.8%
Q3 2020$1,220,000
-5.2%
70,075
-8.4%
0.06%
-9.9%
Q2 2020$1,287,000
+45.6%
76,525
+2.9%
0.07%
+47.9%
Q1 2020$884,000
+95.1%
74,356
+98.6%
0.05%
+152.6%
Q4 2019$453,000
-13.9%
37,436
-0.2%
0.02%
+26.7%
Q3 2018$526,000
-65.5%
37,505
-61.3%
0.02%
-65.9%
Q2 2018$1,523,000
-39.9%
96,865
-37.2%
0.04%
-47.0%
Q1 2018$2,536,000
-44.9%
154,145
-39.5%
0.08%
-42.4%
Q4 2017$4,599,000
-10.4%
254,636
-4.3%
0.14%
-15.8%
Q3 2017$5,135,000
+64.8%
266,085
+0.8%
0.17%
+78.1%
Q2 2017$3,116,000
+230.1%
264,095
+206.6%
0.10%
+255.6%
Q1 2017$944,000
+50.8%
86,140
-0.0%
0.03%
+50.0%
Q4 2016$626,000
+281.7%
86,170
+186.5%
0.02%
+260.0%
Q2 2016$164,000
+97.6%
30,080
+69.2%
0.01%
+150.0%
Q1 2016$83,000
+22.1%
17,780
+31.0%
0.00%0.0%
Q4 2015$68,00013,5700.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders